Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,355,187 papers from all fields of science
Search
Sign In
Create Free Account
etoprine
Known as:
DDEP
, 2,4-Diamino-5-(3,4-dichlorophenyl)-6-ethylpyrimidine
, 2,4-diamino-5- (3',4'-dichlorophenyl)-6-ethylpyrimidine
Expand
A lipophilic, diaminopyrimidine folate antagonist with potential antineoplastic activity. Etoprine inhibits dihydrofolate reductase, resulting in…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
NCIt Antineoplastic Agent Terminology
analogs & derivatives
Broader (1)
Pyrimethamine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Long-term trends in total inorganic nitrogen and sulfur deposition in the U.S. from 1990 to 2010.
Yuqiang Zhang
,
R. Mathur
,
J. Bash
,
C. Hogrefe
,
J. Xing
,
S. Roselle
Atmospheric Chemistry and Physics
2018
Corpus ID: 51924627
Excess deposition (including both wet and dry deposition) of nitrogen and sulfur are detrimental to ecosystems. Recent studies…
Expand
Highly Cited
2010
Highly Cited
2010
The discordance of diversification: evolution in the tropical‐montane frogs of the Eastern Arc Mountains of Tanzania
Lucinda P. Lawson
Molecular Ecology
2010
Corpus ID: 22023525
Species with similar geographical distribution patterns are often assumed to have a shared biogeographical history, an assumption…
Expand
Highly Cited
1999
Highly Cited
1999
Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes.
Huifen Wang
,
Maria-Emilia Figueiredo Pereira
,
Maria Almira Correia
Archives of Biochemistry and Biophysics
1999
Corpus ID: 41549800
Mechanism-based inactivation of liver microsomal cytochromes P450 3A (CYP 3A, P450s 3A) in vivo and/or in vitro, via heme…
Expand
Highly Cited
1992
Highly Cited
1992
Degradation of rat liver cytochromes P450 3A after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: characterization of the proteolytic system.
M. Correia
,
S. Davoll
,
S. Wrighton
,
P. Thomas
Archives of Biochemistry and Biophysics
1992
Corpus ID: 30493330
1992
1992
Differential apoprotein loss of rat liver cytochromes P450 after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: a case for distinct proteolytic mechanisms?
M. Correia
,
K. Yao
,
S. Wrighton
,
D. Waxman
,
A. Rettie
Archives of Biochemistry and Biophysics
1992
Corpus ID: 46054096
1988
1988
4-alkyl radical extrusion in the cytochrome P-450-catalyzed oxidation of 4-alkyl-1,4-dihydropyridines.
Jae S. Lee
,
Neil E. Jacobsen
,
P. Ortiz de Montellano
Biochemistry
1988
Corpus ID: 21989781
Rat liver microsomal cytochrome P-450 oxidizes the 4-methyl, 4-ethyl (DDEP), and 4-isopropyl derivatives of 3,5-bis(carbethoxy)-2…
Expand
Highly Cited
1987
Highly Cited
1987
Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adducts.
M. Correia
,
C. Decker
,
+5 authors
W. Trager
Archives of Biochemistry and Biophysics
1987
Corpus ID: 23719047
Highly Cited
1982
Highly Cited
1982
The catalytic mechanism of cytochrome P-450. Spin-trapping evidence for one-electron substrate oxidation.
O. Augusto
,
H. S. Beilan
,
P. Ortiz de Montellano
Journal of Biological Chemistry
1982
Corpus ID: 28102070
Highly Cited
1981
Highly Cited
1981
N-Alkylprotoporphyrin IX formation in 3,5-dicarbethoxy-1,4-dihydrocollidine-treated rats. Transfer of the alkyl group from the substrate to the porphyrin.
P. Ortiz de Montellano
,
H. S. Beilan
,
K. Kunze
Journal of Biological Chemistry
1981
Corpus ID: 25152761
Highly Cited
1978
Highly Cited
1978
Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man.
J. Cavallito
,
C. A. Nichol
,
+4 authors
C. W. Sigel
Drug Metabolism And Disposition
1978
Corpus ID: 13483434
With the aim of developing anticancer compounds which overcome some of the clinical limitations of the polar dihydrofolate…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE